tiprankstipranks
Trending News
More News >
Cidara Therapeutics (CDTX)
NASDAQ:CDTX
US Market

Cidara Therapeutics (CDTX) Ratios

Compare
743 Followers

Cidara Therapeutics Ratios

CDTX's free cash flow for Q1 2025 was $0.00. For the 2025 fiscal year, CDTX's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.50 0.90 1.50 2.11 1.48
Quick Ratio
1.50 0.81 1.50 2.18 1.48
Cash Ratio
1.09 0.53 1.09 1.83 0.93
Solvency Ratio
-0.59 -0.30 -0.59 -0.81 -1.45
Operating Cash Flow Ratio
-0.95 -0.33 -0.95 -0.74 -1.41
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 -6.75 -6.83
Net Current Asset Value
$ -5.40M$ -14.38M$ -5.40M$ 17.95M$ 7.48M
Leverage Ratios
Debt-to-Assets Ratio
0.03 0.07 0.03 0.07 0.13
Debt-to-Equity Ratio
-0.45 -0.59 -0.45 0.23 0.74
Debt-to-Capital Ratio
-0.83 -1.46 -0.83 0.19 0.43
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
-16.39 -8.16 -16.39 3.49 5.64
Debt Service Coverage Ratio
-176.08 0.00 -176.08 -11.06 -8.73
Interest Coverage Ratio
-155.59 0.00 -155.59 -199.32 -274.23
Debt to Market Cap
0.00 0.00 0.00 0.06 0.10
Interest Debt Per Share
0.43 1.12 0.43 2.01 3.96
Net Debt to EBITDA
0.94 1.27 0.94 1.35 0.39
Profitability Margins
Gross Profit Margin
99.78%97.62%99.78%99.62%-463.66%
EBIT Margin
-52.11%-38.31%-52.11%-85.24%-595.42%
EBITDA Margin
-51.89%-38.13%-51.89%-85.24%-593.05%
Operating Profit Margin
-46.23%-38.31%-46.23%-85.24%-595.42%
Pretax Profit Margin
-45.93%-35.19%-45.93%-85.67%-597.59%
Net Profit Margin
-46.35%-35.88%-46.35%-88.58%-599.76%
Continuous Operations Profit Margin
-52.24%-35.88%-52.24%-85.67%-597.59%
Net Income Per EBT
100.92%101.97%100.92%103.40%100.36%
EBT Per EBIT
99.36%91.85%99.36%100.50%100.36%
Return on Assets (ROA)
-62.61%-34.21%-62.61%-58.29%-119.78%
Return on Equity (ROE)
1026.14%279.31%1026.14%-203.54%-675.44%
Return on Capital Employed (ROCE)
-168.65%6310.05%-168.65%-102.29%-328.68%
Return on Invested Capital (ROIC)
-159.26%-2737.42%-159.26%-94.58%-234.42%
Return on Tangible Assets
-62.61%-34.21%-62.61%-58.29%-119.78%
Earnings Yield
-56.39%-33.03%-56.39%-65.95%-87.08%
Efficiency Ratios
Receivables Turnover
11.02 3.93 11.02 9.26 1.08
Payables Turnover
0.10 0.40 0.10 0.15 14.89
Inventory Turnover
143.00K 0.25 143.00K -0.07 0.00
Fixed Asset Turnover
45.05 12.46 45.05 19.49 9.97
Asset Turnover
1.35 0.95 1.35 0.66 0.20
Working Capital Turnover Ratio
2.44 14.93 2.44 1.76 0.44
Cash Conversion Cycle
-3.66K 650.00 -3.66K -7.48K 313.51
Days of Sales Outstanding
33.12 92.79 33.12 39.44 338.02
Days of Inventory Outstanding
<0.01 1.46K <0.01 -5.01K 0.00
Days of Payables Outstanding
3.69K 903.99 3.69K 2.51K 24.51
Operating Cycle
33.12 1.55K 33.12 -4.97K 338.02
Cash Flow Ratios
Operating Cash Flow Per Share
-8.15 -5.13 -8.15 -9.63 -26.19
Free Cash Flow Per Share
-8.19 -5.25 -8.19 -9.64 -26.28
CapEx Per Share
0.03 0.12 0.03 0.02 0.09
Free Cash Flow to Operating Cash Flow
1.00 1.02 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-241.30 -44.42 -241.30 -615.41 -292.53
Capital Expenditure Coverage Ratio
-241.30 -44.42 -241.30 -615.41 -292.53
Operating Cash Flow Coverage Ratio
-21.62 -4.60 -21.62 -4.99 -6.83
Operating Cash Flow to Sales Ratio
-0.44 -0.35 -0.44 -0.51 -4.51
Free Cash Flow Yield
-54.10%-33.04%-54.10%-37.96%-65.69%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-1.77 -3.03 -1.77 -1.52 -1.15
Price-to-Sales (P/S) Ratio
0.82 1.09 0.82 1.34 6.89
Price-to-Book (P/B) Ratio
-18.20 -8.46 -18.20 3.09 7.76
Price-to-Free Cash Flow (P/FCF) Ratio
-1.85 -3.03 -1.85 -2.63 -1.52
Price-to-Operating Cash Flow Ratio
-1.86 -3.09 -1.86 -2.64 -1.53
Price-to-Earnings Growth (PEG) Ratio
0.04 0.08 0.04 0.03 -0.04
Price-to-Fair Value
-18.20 -8.46 -18.20 3.09 7.76
Enterprise Value Multiple
-0.64 -1.58 -0.64 -0.22 -0.77
Enterprise Value
21.43M 38.52M 21.43M 9.37M 55.16M
EV to EBITDA
-0.64 -1.58 -0.64 -0.22 -0.77
EV to Sales
0.33 0.60 0.33 0.19 4.57
EV to Free Cash Flow
-0.75 -1.68 -0.75 -0.37 -1.01
EV to Operating Cash Flow
-0.75 -1.72 -0.75 -0.37 -1.01
Tangible Book Value Per Share
-0.83 -1.88 -0.83 8.23 5.16
Shareholders’ Equity Per Share
-0.83 -1.88 -0.83 8.23 5.16
Tax and Other Ratios
Effective Tax Rate
>-0.01 -0.02 >-0.01 -0.03 >-0.01
Revenue Per Share
18.41 14.62 18.41 18.91 5.81
Net Income Per Share
-8.53 -5.25 -8.53 -16.75 -34.83
Tax Burden
1.01 1.02 1.01 1.03 1.00
Interest Burden
0.88 0.92 0.88 1.01 1.00
Research & Development to Revenue
1.17 1.07 1.17 1.47 5.64
SG&A to Revenue
0.29 0.29 0.29 0.38 1.32
Stock-Based Compensation to Revenue
0.05 0.05 0.05 0.08 0.34
Income Quality
0.96 0.98 0.96 0.59 0.75
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis